Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06994728 · ClinicalTrials.gov registry record · NA

Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait

A NA study of Parkinson Disease and Gait Disorders, Neurologic, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06994728: Recruiting NA study of Parkinson Disease and Gait Disorders, Neurologic, sponsored by Medical University of South Carolina.

NCT06994728 is a NA study of Parkinson Disease and Gait Disorders, Neurologic that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 12 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06994728, a NA study of Parkinson Disease and Gait Disorders, Neurologic, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine how deep brain stimulation (DBS) for Parkinson's disease affects attention and visuospatial function. Additionally, this study will evaluate how deficits in visual attention are associated with freezing of gait (FOG) in Parkinson's disease. There is currently no reliable treatment for FOG and little is understood about the underlying reason this occurs. Some recent research has found that stimulating the right side of the brain seems to improve FOG. The right side of the brain is also paramount for visual attention, which is why investigators are conducting this study.

Primary Outcome

Investigators hypothesize that right STN stimulation will have a significant association with reduction in freezing of gait, as measured by timed up and go task, compared to left STN stimulation and no stimulation.

Interventions

  • DEVICE Left STN-DBS on, right STN-DBS off first
  • DEVICE Right STN-DBS on, left STN-DBS off first

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2025-04-01
Est. Completion 2026-06
Phase NA

What NCT06994728 shows while recruiting

NCT06994728 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Left STN-DBS on, right STN-DBS off first is the first listed.

NCT06994728 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT06994728 about?

NCT06994728 is a clinical study titled "Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait". The purpose of this research is to determine how deep brain stimulation (DBS) for Parkinson's disease affects attention and visuospatial function. Additionally, this study will evaluate how deficits in visual attention are associated with freezing of gait (FOG) in Parkinson's disease. There is curre...

What is the current status of trial NCT06994728?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-04-01. Estimated completion is 2026-06.

What conditions does trial NCT06994728 study?

This clinical trial studies the following conditions: Parkinson Disease, Gait Disorders, Neurologic, Visuospatial/Perceptual Abilities.

What interventions are being tested in trial NCT06994728?

The interventions under investigation include: Left STN-DBS on, right STN-DBS off first (DEVICE), Right STN-DBS on, left STN-DBS off first (DEVICE).

Who is sponsoring clinical trial NCT06994728?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06994728 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06994728's enrollment target sits among peer trials

12 268th of 297 higher than 24 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06994728, the US trial registry maintained by the National Library of Medicine. NCT06994728 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.